135 related articles for article (PubMed ID: 19038421)
1. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population.
Bogdanovic L; Lazic M; Bogdanovic J; Soldatovic I; Nikolic N; Radunovic M; Radojevic-Skodric S; Milasin J; Basta-Jovanovic G
J BUON; 2017; 22(1):270-277. PubMed ID: 28365965
[TBL] [Abstract][Full Text] [Related]
4. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
Cheng ZJ; Hu LH; Huang SJ
Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
[TBL] [Abstract][Full Text] [Related]
5. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
7. Survivin promoter polymorphism and cervical carcinogenesis.
Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
9. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.
Ahirwar D; Kesarwani P; Manchanda PK; Mandhani A; Mittal RD
Cancer Genet Cytogenet; 2008 Jul; 184(1):1-8. PubMed ID: 18558283
[TBL] [Abstract][Full Text] [Related]
10. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of GSTO1 and SULT1A1 polymorphisms and cigarette smoking on urothelial carcinoma risk in a Taiwanese population.
Tung MC; Wang YH; Yeh SD; Wu CC; Chen KC; Huang ZM; Huang MT; Chiou HY
J Formos Med Assoc; 2014 Sep; 113(9):640-7. PubMed ID: 25103078
[TBL] [Abstract][Full Text] [Related]
12. Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.
Wang YH; Yeh SD; Shen KH; Shen CH; Tung MC; Liu CT; Chiou HY
Anticancer Res; 2011 Nov; 31(11):3939-44. PubMed ID: 22110223
[TBL] [Abstract][Full Text] [Related]
13. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
Nohara H; Okayama N; Inoue N; Koike Y; Fujimura K; Suehiro Y; Hamanaka Y; Higaki S; Yanai H; Yoshida T; Hibi T; Okita K; Hinoda Y
J Gastroenterol; 2004; 39(3):242-6. PubMed ID: 15065001
[TBL] [Abstract][Full Text] [Related]
14. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
17. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
18. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
19. Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking.
Wang H; Liu Y; Tan W; Zhang Y; Zhao N; Jiang Y; Lin C; Hao B; Zhao D; Qian J; Lu D; Jin L; Wei Q; Lin D; He F
Cancer Sci; 2008 Apr; 99(4):787-91. PubMed ID: 18294291
[TBL] [Abstract][Full Text] [Related]
20. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
